Want to join the conversation?
As a result of its 2Q16 results, $CTAS updated its 2016 annual guidance. The company now expects its fiscal 2016 revenue to be in the range of $4.825-4.880Bil and fiscal 2016 EPS from continuing operations to be in the range of $3.83-3.90. This guidance does not include any potential deterioration in the U.S. economy or share buybacks.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.